ReviewInflammopharmacology2026

RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases.

Nazila Heidari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.